ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 178 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $260,000 | -20.0% | 20,867 | -12.1% | 0.00% | 0.0% |
Q3 2016 | $325,000 | +90.1% | 23,746 | +2.5% | 0.00% | +100.0% |
Q2 2016 | $171,000 | -10.5% | 23,170 | -22.4% | 0.00% | -50.0% |
Q1 2016 | $191,000 | -37.6% | 29,848 | -39.0% | 0.00% | -33.3% |
Q4 2015 | $306,000 | +1.0% | 48,966 | -5.5% | 0.00% | 0.0% |
Q3 2015 | $303,000 | -29.2% | 51,800 | +0.0% | 0.00% | -25.0% |
Q2 2015 | $428,000 | +14.7% | 51,784 | +14.4% | 0.00% | 0.0% |
Q1 2015 | $373,000 | +17.3% | 45,251 | -2.4% | 0.00% | 0.0% |
Q4 2014 | $318,000 | +42.6% | 46,346 | +12.1% | 0.00% | +33.3% |
Q3 2014 | $223,000 | +24.6% | 41,341 | +46.7% | 0.00% | 0.0% |
Q2 2014 | $179,000 | -39.3% | 28,174 | -22.9% | 0.00% | -25.0% |
Q1 2014 | $295,000 | +143.8% | 36,549 | +106.4% | 0.00% | +100.0% |
Q4 2013 | $121,000 | – | 17,712 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |